02/05/2025
3:40 PM | Flagship V VentureLabs Rx Fund, L.P. (Filed by)
Omega Therapeutics (Subject)
| Form SCHEDULE 13D/A | |
02/05/2025
2:57 PM | Omega Therapeutics (Subject)
Young Richard A (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/04/2025
8:59 PM | Omega Therapeutics (Issuer)
Varsalone Jeffrey T (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/17/2025
4:00 PM | Omega Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/10/2025
3:47 PM | Omega Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/31/2024
4:37 PM | Flagship Ventures Fund V, L.P. (Filed by)
Omega Therapeutics (Subject)
| Form SCHEDULE 13D/A | |
12/31/2024
4:30 PM | Omega Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/06/2024
4:00 PM | Omega Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/05/2024
3:05 PM | Mehrotra Ravi (Reporting)
Omega Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/26/2024
5:27 PM | Nelson Jennifer Ann (Reporting)
Omega Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/26/2024
5:31 PM | Nelson Jennifer Ann (Reporting)
Omega Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for OMGA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Omega Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
11/15/2024
5:09 PM | Certel Kaan (Reporting)
Omega Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
4:10 PM | Omega Therapeutics (Issuer)
Rosiello Robert L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
4:00 PM | Omega Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/04/2024
4:01 PM | Omega Therapeutics (Issuer)
Rosiello Robert L. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/30/2024
3:01 PM | Omega Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/06/2024
6:02 AM | Omega Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/06/2024
6:03 AM | Omega Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/21/2024
3:15 PM | Kender Richard N (Reporting)
Omega Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
05/31/2024
3:49 PM | Chan Barbara Y (Reporting)
Omega Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
05/31/2024
3:50 PM | Certel Kaan (Reporting)
Omega Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
05/31/2024
3:57 PM | Certel Kaan (Reporting)
Omega Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2024
4:04 PM | Omega Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/30/2024
4:10 PM | Omega Therapeutics (Filer)
| Form 8-K/A | |
05/06/2024
6:04 AM | Omega Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/06/2024
6:06 AM | Omega Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/29/2024
6:15 AM | Omega Therapeutics (Filer)
| Form DEFA14A | |
04/29/2024
6:00 AM | Omega Therapeutics (Filer)
| Form DEF 14A | |
04/16/2024
3:20 PM | Omega Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Free OMGA Stock Alerts